PAR vs PARKHOSPS: Stock Comparison

Par Drugs And Chemicals Limited vs Park Medi World Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Park Medi World Ltd is the larger company by market capitalisation. Par Drugs And Chemicals Limited shows a lower P/E and lower leverage, while Park Medi World Ltd shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Par Drugs And Chemicals Limited and Park Medi World Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, PAR is more favourable on 4 of 13 scored metrics and PARKHOSPS on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
PARKHOSPS is the larger company
₹12,051 Cr vs ₹116 Cr
P/E Ratio
PAR has a lower P/E
8.55x vs 46.75x
P/B Ratio
PAR has a lower P/B
0x vs 5.97x
EPS
PAR has higher earnings per share
₹10.65 vs ₹5.98
Revenue Growth (TTM YoY)
PARKHOSPS has faster revenue growth
0% vs -12.2%
EPS Growth (TTM YoY)
PARKHOSPS has faster EPS growth
0% vs -48.5%
Qtr Sales Growth
PARKHOSPS has stronger quarterly sales growth
30.1% vs -12.2%
Qtr Profit Growth
PARKHOSPS has stronger quarterly profit growth
58% vs -48.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricPARPARKHOSPS
SectorHealthcare
IndustryPharmaceuticals

Price

MetricPARPARKHOSPS
Live Price₹93.79₹280.25
Day Change-2.48%-1.25%
Volume12,0631.94 L
52-Week High₹114₹305
52-Week Low₹78.05₹138.1
Distance from 52W High-17.73%-8.11%

Valuation

MetricPARPARKHOSPS
Market Cap₹116 Cr₹12,051 Cr
P/E Ratio8.55x46.75x
P/B Ratio0x5.97x
EPS₹10.65₹5.98
Book Value₹90.52₹46.8
Dividend Yield0%0%

Growth

MetricPARPARKHOSPS
Revenue Growth (TTM YoY)-12.2%0%
EPS Growth (TTM YoY)-48.5%0%
Qtr Sales Growth-12.2%30.1%
Qtr Profit Growth-48.5%58%

Profitability & Leverage

MetricPARPARKHOSPS
ROE12.4%16.7%
ROCE16.5%19.3%
Net Margin12.65%16.29%
Operating Margin16.5%26.5%
Debt to Equity0x0.18x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricPARPARKHOSPS
Promoter Holding73.41%82.89%
FII Holding0%0.82% 0.04 pp
DII Holding0.09% 0.09 pp8.95% 0.3 pp
Public Holding26.51% 0.08 pp7.33% 0.34 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Par Drugs And Chemicals Limited and Park Medi World Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.